SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Metagenics, Inc., a leading developer and manufacturer of science-based medical foods and nutraceuticals sold through healthcare practitioners, announced today that it has been awarded three new patents for discoveries relating to Luduxin™ and Tetrase™, two all-natural selective kinase response modifier (SKRM) formulations with powerful anti-inflammatory properties.
